N-acetylglutamate | Urea Cycle Disorders Consortium

Skip to main content

Search

Join Our Contact Registry

Header Social Media

Main navigation

Our Research
Patients and Families
Researchers and Clinicians
Early Stage Investigators
News and Events
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

A coenzyme that assists in processing the first step of the urea cycle and activates carbamoyl phosphate synthetase I.

Footer menu

Web Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Urea Cycle Disorders Consortium (UCDC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). UCDC is funded under grant number U54HD061221 as a collaboration between NCATS, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the UCDC, whose administrative coordinating center is located at Children’s National Research and Innovation (Children’s Research Institute), and does not necessarily represent the official views of the NIH.

social media